Jun 02, 2020 / 12:00PM GMT
Presentation
Jun 02, 2020 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Daniel P. Gold
MEI Pharma, Inc. - President, CEO & Director
* Richard G. Ghalie
MEI Pharma, Inc. - SVP of Clinical Development
=====================
Conference Call Participants
=====================
* Adam Gerald Evertts
LifeSci Capital, LLC, Research Division - Senior Research Analyst
* I-Eh Jen
Laidlaw & Company (UK) Ltd., Research Division - MD of Healthcare Research & Senior Biotechnology Analyst
* James William Birchenough
Wells Fargo Securities, LLC, Research Division - MD and Senior Biotechnology Analyst
* Matthew David Cross
JonesTrading Institutional Services, LLC, Research Division - Research Analyst
* Srikripa Devarakonda
SunTrust Robinson Humphrey, Inc., Research Division - Associate
* Stephen Douglas Willey
Stifel, Nicolaus & Company, Incorporated, Research Division - Director
* Thomas Eugene Shrader
BTIG,
MEI Pharma Inc
(NAS:MEIP)
$
3.16
0.085 (2.76%)
Market Cap: 21.05 Mil
Enterprise Value: -17.79 Mil
PE Ratio: 1.19
PB Ratio: 0.64
GF Score: 57/100 MEI Pharma Inc Post-ASCO Virtual Scientific Program Investor and Analyst Presentation Transcript
Jun 02, 2020 / 12:00PM GMT
Release Date Price:
$83
(-0.95%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot